• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

INVO BioScience, Inc. - Common Stock (NQ:INVO)

0.8330 UNCHANGED
Last Price Updated: 3:55 PM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about INVO BioScience, Inc. - Common Stock

Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
April 19, 2024
Via AB Newswire
INVO Bioscience Inc. (NASDAQ: INVO) is One of Wednesday Morning’s Most Active Stocks
April 17, 2024
Via Investor Brand Network
News headline image
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
January 23, 2024
From NAYA Biosciences
Via GlobeNewswire
News headline image
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
January 17, 2024
From NAYA Biosciences
Via GlobeNewswire
INVO Bioscience Inc. (NASDAQ: INVO) Leading the Way in Tuesday Trading Based on Percentage Gain
November 14, 2023
Via Investor Brand Network
BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger
November 13, 2023
Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a... 
Via TheNewswire.com
News headline image
INVO BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of INVO Bioscience, Inc. - INVO
October 24, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
INVO Bioscience Inc. (NASDAQ: INVO) is One of Monday Morning’s Most Active Stocks
October 23, 2023
Via Investor Brand Network
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), Hess Corporation (NYSE – HES), Textainer Group Holdings Limited (NYSE – TGH), INVO Bioscience, Inc. (Nasdaq – INVO)
October 23, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
October 24, 2023
EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
INVO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of INVO Bioscience, Inc. Is Fair to Shareholders
October 23, 2023
From Halper Sadeh LLC
Via Business Wire
News headline image
INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers'
February 09, 2022
SAN FRANCISCO, CA / ACCESSWIRE / February 9, 2022 / Today, the global fertility market is a multi-billion industry, yet remains severely underserved, with estimates suggesting more than 90% of couples... 
From INVO Bioscience, Inc.
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap